|
Ex Vivo Drug Response Profiling in
Clinical Application |
 |
November 14, 2024 (Thursday) |
 |
EST 10:00 / GMT 15:00 / CET 16:00 |
|
|
 |
| Peter-Martin Bruch |
| • |
Resident Physician and Physician Scientist,
University Hospital Düsseldorf |
|
| • |
Recipient of the Franziska-Kolb-Foundation
Research Award |
|
|
The webinar record will be shared to the registrants.
Webinar certificate is available.
(Please send the request to: Marketing@medchemexpress.com) |
| In This Webinar, You Will Learn: |
| • |
How ex vivo drug response profiling can reveal genotype–drug response associations |
| • |
The feasibility and clinical impact of ex vivo drug response profiling for personalized
treatment guidance in hematologic malignancies |
| • |
Future potential application of ex vivo drug response profiling in precision medicine |
|
| About This Webinar: |
| ex vivo drug response profiling has emerged as a promising tool for studying genotype–drug response associations, offering the potential for precision medicine, especially in cancer treatment. In this webinar, Peter-Martin Bruch will discuss the findings from the SMARTrial (NCT03488641), a prospective non-interventional trial that investigated the feasibility of ex vivo drug response profiling for guiding treatment decisions in hematologic malignancies. With a 91% of study results delivered within seven days, the trial highlighted the feasibility of this approach. More importantly, it showed in vivo therapy response beyond known genetic risk factors, demonstrating how functional profiling can enhance risk stratification and treatment personalization beyond traditional genetic markers. |
|
|
| MCE Webinar |
The MCE webinar is committed to offering an official platform for global experts and researchers in the fields of medicine, pharmacy, biology, and chemistry.
By facilitating knowledge exchange, the MCE webinar aims to contribute to the global biopharmaceutical industry by promoting extensive sharing of information and expertise. |
|
|
|
|
|
|
|
|
Products are for research use only and are not intended for human use. We do not sell to patients.
|
|
|
